NCT02936102 2025-11-14
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Novartis
Phase 1 Terminated
Novartis
Seoul National University Hospital
European Organisation for Research and Treatment of Cancer - EORTC
City of Hope Medical Center